B
Bolt Biotherapeutics D
D
BOLT
4.94000
USD
0.04
(0.82%)
مغلق
حجم التداول
1,788
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
9,492,541
العنوان: Bolt Biotherapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.